We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
-11.95%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$270M
AUM Growth
-$91.5M
Cap. Flow
-$47.5M
Cap. Flow %
-17.6%
Top 10 Hldgs %
29.27%
Holding
186
New
6
Increased
34
Reduced
74
Closed
23

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$7.06M
2
UNH icon
UnitedHealth
UNH
+$6.09M
3
ZTS icon
Zoetis
ZTS
+$5.52M
4
ULTA icon
Ulta Beauty
ULTA
+$3.73M
5
VZ icon
Verizon
VZ
+$479K

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$7.85M
2
PSX icon
Phillips 66
PSX
+$7.78M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$7.68M
4
SCHW
Charles Schwab
SCHW
+$7.42M
5
CTAS icon
Cintas
CTAS
+$7.25M

Sector Composition

Rank Sector Weight
1 Healthcare 24.65%
2 Technology 17.48%
3 Financials 9.53%
4 Industrials 8.75%
5 Consumer Discretionary 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLB icon
176
SLB Ltd
SLB
$75B
-5,275
Closed -$321K
SU icon
177
Suncor Energy
SU
$70.3B
-6,930
Closed -$268K
VLO icon
178
Valero Energy
VLO
$85.9B
-1,770
Closed -$201K
VTV icon
179
Vanguard Morningstar Value ETF
VTV
$191B
-1,934
Closed -$214K
GRUB
180
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
-850
Closed -$236K
ESRX
181
DELISTED
Express Scripts Holding Company
ESRX
-4,113
Closed -$391K
PBM
182
DELISTED
PACIFIC BOOKER MINERALS INC.
PBM
-57,000
Closed -$36K

Similar funds

Dixon Hubard Feinour & Brown's Q4 2018 Portfolio in Review

As of Q4 2018, Dixon Hubard Feinour & Brown held 186 positions worth $270M, down 25% from $362M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Dixon Hubard Feinour & Brown withdrew a net $47.5M in Q4 2018, closing 23 positions and reducing 74 holdings. Its most notable exit was Amphenol, an estimated $7.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Dixon Hubard Feinour & Brown opened a new position in Edwards Lifesciences worth $7.12M.

  • Dixon Hubard Feinour & Brown's largest Q4 2018 buy was Edwards Lifesciences: 139,536 shares worth $7.12M.
  • Dixon Hubard Feinour & Brown added most to UnitedHealth in Q4 2018, an estimated $6.09M increase.
  • Dixon Hubard Feinour & Brown's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $7.68M.
  • Dixon Hubard Feinour & Brown fully exited Amphenol in Q4 2018, selling an estimated $7.85M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 29% of its $270M portfolio in Q4 2018.
  • Dixon Hubard Feinour & Brown opened 6 new positions and closed 23 in Q4 2018.
  • Dixon Hubard Feinour & Brown's portfolio value fell 25% quarter-over-quarter to $270M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2018, filed 13 Feb 2019.